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on day 0 and 7. 10 Wistar rats were used as control, with injection of
0.05M acetic acid. On day 16 all 10 CIA rats were diseased, determined
by swollen paws. All the rats were scariﬁed at day 26. Blood was taken
at baseline, during the experiment and at termination and used for
biomarkers measurements. Disease onset was deﬁned as the day with
signiﬁcant difference between the paw score (swelling of paws) of SHAM
and CIA. ELISAs were used to quantitatively measure turnover of type III
collagen, CO3–610 to detect degradation and PIIINP to detect formation.
A novel competitive ELISA (s-NysCo3) was used to detect nitrosylation
of mature type III collagen.
Results: A 40% increase in degradation of type III collagen was detected
in CIA rats after disease onset, but no signiﬁcant increase in formation
of type III collagen was detected. However, there was a tendency of
increased formation of type III collagen in CIA rats after disease onset.
These results led to a 40% increase of type III collagen turnover in the
diseased CIA rats and this increase of turnover was already, though not
signiﬁcant, detected at day 7. The nitrosylation of mature type III collagen
was detected with at novel competitive ELISA, showing a tendency of
increased nitrosylation of type III collagen in CIA rats after disease onset.
However, when comparing the amount of nitrosylation to the amount of
degraded type III collagen, a decrease in nitrosylation of type III collagen
was detected.
Conclusions: Collagen induced arthritis in rats increased type III collagen
turnover after disease onset and the level of nitrosylation of tyrosines
was elevated compared to SHAM. However, the level of nitrosylation in
CIA rats compared to the turnover of type III collagen showed lower a
nitrosylation rate. This could be a direct effect of the increased amount
of degradation of type III collagen in the CIA rats. In conclusion, the level
nitrosylation of type III collagen is depended of the turnover of type III
collagen.
128
INHIBITION OF TRANSFORMING GROWTH FACTOR ALPHA SIGNALING
SLOWS PROGRESSION OF OSTEOARTHRITIS
S.E. Usmani, T.C. Appleton, V. Ulici, I.D. Welch, T.L. Hill, F. Beier. The Univ.
of Western Ontario, London, ON, Canada
Purpose: No cures currently exist for the degenerative joint disease
osteoarthritis (OA). Furthermore, the complex and multi-variable nature
of OA continues to challenge the development of effective therapies. In an
attempt to identify potential targets for disease modifying osteoarthritis
drugs (DMOADs), our lab recently established a surgical model of OA to
study gene expression changes in degenerating cartilage. Transforming
growth factor alpha (TGFa) gene expression was upregulated in our
model and further in vitro studies showed that TGFa suppressed
chondrocyte expression of anabolic factors aggrecan and type II collagen
and increased expression of the catabolic factor matrix metalloproteinase
13 (MMP13). We thus identiﬁed TGFa as a novel therapeutic OA target.
The purpose of this project is to examine the role of TGFa in the
development of OA in vivo. We hypothesize that inhibition of TGFa
signaling will delay disease progression in surgical OA models.
Methods: Adult male Tgfa null mice and control littermates received
either meniscotibial transection (MTX) or sham surgery. At 7 and
14 weeks post-surgery knee joint histopathology was assessed using
the OARSI scoring method and tissues were immunostained for disease
markers such as MMP13 and type II collagen neoepitopes. Since
some features of cartilage and bone development are known to be
recapitulated during the disease process, skeletal development in Tgfa
null mice was also examined.
Results: MTX surgery produced mild and moderate OA in mice after 7
and 14 weeks. Tgfa null mice had lower OARSI scores and expressed less
MMP13 and type II collagen neoepitopes than their control littermates.
Tgfa null mice also showed transient growth retardation after birth.
Histological analyses demonstrated a wider hypertrophic zone of the
growth plate. TRAP staining showed a decrease in osteoclasts at
the cartilage-bone interface, suggesting that removal of hypertrophic
cartilage is delayed. These phenotypes are absent in adult mice.
Conclusions: TGFa signaling plays an important role in osteoarthritis
progression in vivo and should be investigated further as a potential
target for DMOAD development.
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Purpose: Intra-articular injection of monoiodoacetate (MIA) in the
rodent joint can cause chondrocyte death and subsequent cartilage
degeneration. It can also lead to subchondral bone degradation and
gait alteration. Therefore it is considered a useful osteoarthritis model to
evaluate pharmaceutical and biologic agents to inhibit cartilage and bone
degeneration and alleviate pain. The severity of pain/gait alteration and
structural damage depend on MIA concentration and injection frequency.
However it is unknown if there is any correlation between pain and
structural damage over time. This study investigates how the pain/gait
change correlates with structural damages longitudinally at two MIA
doses in rat. It was hypothesized that the gait and structural changes
would exhibit a similar trend during the post-MIA injection period.
Methods: Two groups of Sprague Dawley rats (n = 12/group) were
injected with 0.5mg or 2mg of MIA (40ml) on day 0 on their right knees.
Gait analysis, incapacitance testing, and knee diameter measurement
were performed before MIA injection and on days 3, 7, 14, 21, 28, and
35 days post-injection. Animals were sacriﬁced on days 21 (n =4) and 35
(n =8) for microCT and histopathologic evaluation. For microCT, the right
knee from each animal was scanned at a norminal resolution of 18mm
using Scanco mCT80. Bone volume of distal condyles was determined.
For histopathology, the right knees were trimmed into two equal frontal
halves, ﬁxed, decalciﬁed, embedded in parafﬁn and sectioned. Sctions
were stained with toluidine blue and examined microscopically. Cartilage
matrix damage, bone resorption, bone sclerosis and osteophyte were
scored for each sample. All data were expressed as Mean±SD. Two-way
ANOVA and post-hoc Tukey’s HSD testing or non-parametric testing were
performed with P < 0.05 considered signiﬁcant.
Fig. 1. Deﬁciency of right to total hindleg weight distribution by
incapacitance test.
Fig. 2. Representative microCT images of distal femur.
